Monoclonal immunoglobulin deposition disease: light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis. Clinical features, immunopathology, and molecular analysis.
about
Pathogenic potential of human monoclonal immunoglobulin light chains: relationship of in vitro aggregation to in vivo organ depositionStructure of a monoclonal kappa chain of the V kappa IV subgroup in the kidney and plasma cells in light chain deposition disease.Amyloid-like IgM deposition neuropathy: a distinct clinico-pathologic and proteomic profiled disorderA case of isolated light chain deposition disease in the duodenum.Molecular anatomy and the pathological expression of antibody light chains.Cardiac nonamyloidotic immunoglobulin deposition disease.Systemic lambda light-chain deposition presenting with predominant cardiac involvement.Retinal pigment epithelial detachments and tears, and progressive retinal degeneration in light chain deposition disease.Pathology of glomerular deposition diseases.Primary cystic lung light chain deposition disease: a clinicopathologic entity derived from unmutated B cells with a stereotyped IGHV4-34/IGKV1 receptor.Long-term reversibility of renal dysfunction associated to light chain deposition disease with bortezomib and dexamethasone and high dose therapy and autologous stem cell transplantation.Management of myeloma-associated renal dysfunction in the era of novel therapies.Light chain deposition disease affecting the gastrointestinal tract in the setting of post-living donor kidney transplantation.Protein fibrillation and nanoparticle interactions: opportunities and challenges.Paraprotein-Related Kidney Disease: Glomerular Diseases Associated with Paraproteinemias.Monoclonal gammopathy of renal significance: Diagnostic workup.The Lung in Dysregulated States of Humoral Immunity.Clinicopathological characteristics and outcomes of light chain deposition disease: an analysis of 48 patients in a single Chinese center.Binding of nascent collagen by amyloidogenic light chains and amyloid fibrillogenesis in monolayers of human fibrocytes.Portal hypertension related to light chain deposition disease of liver: an enlightening experience.Plasma Cell Infiltration of the Kidney as a Manifestation of Myeloma: A Report of Three CasesAggregates, crystals, gels, and amyloids: intracellular and extracellular phenotypes at the crossroads of immunoglobulin physicochemical property and cell physiology.Primary structure of a monoclonal kappa chain in myeloma with light chain deposition disease.A residue-specific shift in stability and amyloidogenicity of antibody variable domains.Waldenström's macroglobulinemia-associated renal amyloidosis presenting as a solitary lung mass.Amyloid fibril formation in microwell plates for screening of inhibitors.Expanding the pathologic spectrum of light chain deposition disease: a rare variant with clinical follow-up of 7 years.A model for amyloid fibril formation in immunoglobulin light chains based on comparison of amyloidogenic and benign proteins and specific antibody binding.Development of rapid light-chain deposition disease in hepatic arteries with severe ischemic cholangitis in a multiple myeloma patient treated with melphalan, prednisone and lenalidomide.Light-chain deposition disease of the kidney: a case report.Structure and energetic basis of overrepresented λ light chain in systemic light chain amyloidosis patients.Dysproteinemias and Glomerular Disease.Structure of abnormal heavy chains in human heavy-chain-deposition disease.Clinical characteristics and prognostic factors in multiple myeloma patients with light chain deposition disease.Henry Bence Jones and his protein.A case of recurrent light chain deposition disease after living-related renal transplantation - detailed process of the recurrence.Development of rapidly progressive liver light chain deposition under VAD chemotherapy in multiple myeloma.An unusual clinical course of cardiac Ig deposition disease.Approach to acute renal failure with multiple myeloma: role of plasmapheresis.Clinical and prognostic differences among patients with light chain deposition disease, myeloma cast nephropathy and both.
P2860
Q28610086-A2D03D6F-C046-4C80-AD6D-3B7CC3952FE4Q34265356-B2DCE15F-B6BD-4E85-8537-E8D45BFBD232Q34317497-1FDDFE65-464B-4EE7-89C3-B99F0CE2C28DQ35730915-FD9CADD3-A0E6-4AE7-A0FB-1871B63E9126Q35773630-8F7EB329-12E4-4A15-9D3D-83CCB6304D2FQ36338008-6190BEDD-1F06-485C-A22E-420F11C2007CQ36683758-3EE55AB2-0E30-4984-8434-91362980D5BAQ36786054-9D4F973E-F02D-42E7-AECD-5FDD544A84B9Q36904936-D71BB8C8-9449-4F89-ADBF-178E585944B4Q36948483-F349943F-6241-44B0-9A89-5D84AB470312Q37694425-D90180F2-323F-45CD-8F45-699EF256A241Q37978343-4E6536F7-6F0B-41BD-B406-33ABC10B4133Q38008954-29E035A1-CC7F-4BAE-828A-AF5786FA71A5Q38086743-60FBBE0F-093E-4557-8C06-4314AF59FF3FQ38831139-EE15529F-4ED5-4841-9EF1-F6648ABC9871Q39186665-495A1A5D-F25B-4BFE-9B2E-568BF029C009Q40045962-A56C1004-0350-4638-B9C5-41E7D4E11DD3Q40812235-6E80DBEC-B206-47A9-B7AB-2597F50C4372Q40863540-4DCDB093-7553-44A8-9BEF-7FC19A592AE8Q41369161-0662EB39-F159-4BDC-AEFA-D148BC7321CAQ41513973-9DF466C6-5D48-433D-A277-ADD4EECECD14Q41831737-6412AE16-4C00-4908-8F4E-0ED4A561B66CQ41886217-EB8F1929-D948-4FFD-BC57-B0B082F92E7CQ42028045-4567DDF3-85A1-455D-A238-E800CC38BF0AQ43553373-89D67874-F1D9-40E5-BDBA-2C0D777A05B3Q43776633-2496F554-0FBE-4273-B57E-EE2FA1C96D51Q45254371-57EC0C6B-2E87-405A-98FC-F83448810A50Q46016224-7FCE43A6-8482-4A35-B2C3-54952E01A532Q46186814-F2D71580-863B-443C-BF6F-4D101B98FD0DQ46842330-E1972824-8917-406B-B85C-23A1DCB2A5CEQ47292925-84AA8BDC-E9CD-4CFB-957B-039B209D96A7Q47428714-4AFD0717-9687-465F-8B94-D7E80D545380Q48074837-63D7F620-A530-4031-9B00-64ADF1CE2755Q48313100-4370FE94-51F5-4CCD-B8A1-DD8FC4ED170AQ48762531-D342DF0F-8CED-4600-8C4A-983F7B8473F8Q50507361-783E3ED1-7AE1-48FA-B8CC-57BBF8921CC1Q50747349-744C5C1B-249B-4FB4-AF66-DB10C180CE0FQ51819753-C83D63F0-DDE6-4507-8F13-6066BCD9AB9AQ51962969-68233573-B003-468D-AC1F-4DF1AF2E21F4Q53548217-8B9DB340-9AB8-433B-9AB2-3F25E8AAD678
P2860
Monoclonal immunoglobulin deposition disease: light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis. Clinical features, immunopathology, and molecular analysis.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
Monoclonal immunoglobulin depo ...... ology, and molecular analysis.
@en
Monoclonal immunoglobulin depo ...... ology, and molecular analysis.
@nl
type
label
Monoclonal immunoglobulin depo ...... ology, and molecular analysis.
@en
Monoclonal immunoglobulin depo ...... ology, and molecular analysis.
@nl
prefLabel
Monoclonal immunoglobulin depo ...... ology, and molecular analysis.
@en
Monoclonal immunoglobulin depo ...... ology, and molecular analysis.
@nl
P2093
P1476
Monoclonal immunoglobulin depo ...... ology, and molecular analysis.
@en
P2093
P304
P356
10.7326/0003-4819-76-3-112-6-455
P407
P577
1990-03-01T00:00:00Z